Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

ACAD vs TURF: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ACAD Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 7–3 Matrix Metrics)

ACAD Overall Winner 6-Pillar Tally: ACAD 5 – 1 TURF Matrix Metrics: ACAD 7 – 3 TURF

As of Nov 16, 2026, Acadia Pharmaceuticals Inc. (ACAD) is the stronger overall head-to-head candidate over T. Rowe Price Natural Resource ETF (TURF) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ACAD carries a Unified Composite Score of 42.1/100 (HOLD) at $18.67 (17.0x Forward P/E, 10.2% operating margin), whereas TURF carries 53.5/100 (HOLD) at $32.12 (N/M Forward P/E, N/A operating margin).

  • Composite vs. Pillar Nuance: While TURF currently prints a higher short-term Unified Composite Score (53.5/100 HOLD vs. ACAD 42.1/100 HOLD), ACAD captures the overall institutional head-to-head verdict (7–3 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (10.2% vs. N/A operating margin) and revenue trajectory (+22.8% vs. N/A YoY).
  • Technical & Structure Timing Caution: ACAD is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 41.5); meanwhile TURF is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 33.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About ACAD vs TURF
ACAD NASDAQ Head-to-Head Winner
Acadia Pharmaceuticals Inc.
Pharmaceutical Preparations
$18.67
-0.43% 1D
Market Cap $3.2B
TTM Revenue $1.20B
Forward P/E 17.0x
Beta / 30D Vol 0.13β · 92% Vol
Unified Composite Score
42.1 / 100 HOLD
Tech 43.0 Fund 53.0 Flow 68.0 Mom 50.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -14.8%), weak momentum, RSI 42
RSI-14: 41.5 · SMA20: $19.80 · SMA50: $21.60
TURF NASDAQ
T. Rowe Price Natural Resource ETF
Institutional Equity
$32.12
-2.25% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.47β · 16% Vol
Unified Composite Score
53.5 / 100 HOLD
Tech 34.0 Fund 62.0 Flow 50.0 Mom 73.4
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -2.1%), weak momentum, RSI 33
RSI-14: 33.3 · SMA20: $33.40 · SMA50: $34.08

6-Pillar Scorecard Institutional Category Breakdown (ACAD 5 – 1 TURF)

Columns: Metric · ACAD · TURF
1. Valuation Multiples ACAD
Forward P/E 17.0x N/M
Trailing P/E 8.8x N/M
PEG Ratio N/M N/M
EV / Revenue 2.5x N/M
2. Growth & Scale ACAD
Revenue Growth (YoY) +22.8% N/A
Earnings Growth (YoY) -26.2% N/A
TTM Revenue (USD) $1.20B N/A
Market Cap $3.2B N/A
3. Profitability & Quality ACAD
Gross Margin 63.9% N/A
Operating Margin 10.2% N/A
Net Profit Margin 30.1% N/A
Return on Equity (ROE) 31.4% N/A
4. Balance Sheet & Cash Flow ACAD
Cash Generation (TTM) $181M N/A
Cash Flow Margin 15.0% N/A
Net Cash / Leverage $251M Net Cash N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning TURF
Options Structure Phase BREAKDOWN UNCLASSIFIED
Current IV / %ile 119.0% (20th %ile) N/A (N/A)
Put/Call OI Skew 0.33x (Call-Skewed) N/A
OBV Trend / Tech Phase DISTRIBUTION · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat ACAD
OpEx & R&D Intensity 53.7% of Rev ($646M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Biotechnology Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: ACAD (7) vs TURF (3)
Institutional Metric ACAD TURF Criterion Row Edge
Market Capitalization
Scale
$3.2B N/A Larger Scale ACAD
Trailing P/E Ratio
Valuation
8.8x N/M Lower Multiple ACAD
Forward P/E Ratio
Valuation
17.0x N/M Lower Multiple ACAD
Revenue Growth (YoY)
Growth
+22.8% N/A Higher Growth ACAD
Operating Margin (TTM)
Profitability
10.2% N/A Higher Margin ACAD
Net Profit Margin
Profitability
30.1% N/A Higher Margin ACAD
Return on Equity (ROE)
Capital Efficiency
31.4% N/A Higher ROE ACAD
52-Week Range Position
Momentum
19% ($16–$31) 53% ($27–$37) Stronger Trend TURF
Beta / 30D Volatility
Risk Regime
0.13β · 92% Vol 0.47β · 16% Vol Lower Realized Risk TURF
Unified Institutional Score
Composite Signal
42.1 / 100 (HOLD) 53.5 / 100 (HOLD) Higher Composite TURF
Trailing 12M Revenue (USD)
Operating Scale
$1.20B N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
63.9% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 2.5x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$181M ($251M Net Cash) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon ACAD +4.57 pp
ACAD: -2.35% · TURF: -6.92%
3M Horizon TURF +31.93 pp
ACAD: -38.14% · TURF: -6.21%
6M Horizon TURF +2.35 pp
ACAD: -9.76% · TURF: -7.41%
1Y Horizon TURF +35.98 pp
ACAD: -21.02% · TURF: +14.96%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ACAD vs TURF. Trailing 12-month operating profitability (ACAD 10.2% vs TURF N/A) and valuation multiples (ACAD 17.0x vs TURF N/M Forward P/E) are benchmarked directly in Pillar 4 below.

ACAD ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.20B
Gross Margin63.9%
Op. Margin10.2%
ROE / Fwd P/E31.4% · 17.0x
TURF ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
ACAD BREAKDOWN
58d in phase · OBV DISTRIBUTION
Current IV 119.0%
IV Percentile 20th %ile
Put/Call OI Skew 0.33x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact ACAD Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
TURF UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact TURF Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
ACAD Moat Profile Scale & Operating Efficiency Moat
Biotechnology Operator
Competes within the Biotechnology value chain with $3.2B market capitalization and 10.2% operating margin.
OpEx & R&D Reinvestment 53.7% of Rev ($646M)
90D Engineering Disclosures 0 Published
TURF Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ ACAD vs TURF Key Questions & Quantitative Answers

As of Nov 16, 2026, Acadia Pharmaceuticals Inc. (ACAD) is the stronger overall head-to-head candidate over T. Rowe Price Natural Resource ETF (TURF) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ACAD carries a Unified Composite Score of 42.1/100 (HOLD) at $18.67 (17.0x Forward P/E, 10.2% operating margin), whereas TURF carries 53.5/100 (HOLD) at $32.12 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While TURF currently prints a higher short-term Unified Composite Score (53.5/100 HOLD vs. ACAD 42.1/100 HOLD), ACAD captures the overall institutional head-to-head verdict (7–3 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (10.2% vs. N/A operating margin) and revenue trajectory (+22.8% vs. N/A YoY). Technical & Structure Timing Caution: ACAD is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 41.5); meanwhile TURF is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 33.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

ACAD leads the Growth & Scale pillar: ACAD posts +22.8% YoY revenue growth and -26.2% YoY earnings growth on $1.20B TTM revenue (63.9% gross margin, 10.2% operating margin), compared with TURF at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, ACAD generates $1.20B in USD-normalized revenue versus N/A for TURF. In operating R&D and SG&A reinvestment, ACAD deploys 53.7% of Rev ($646M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for TURF.

ACAD screens cheaper on headline valuation multiples. ACAD trades at 17.0x Forward P/E, 8.8x Trailing P/E, N/M PEG, and 2.5x EV/Revenue (15.0% FCF margin), whereas TURF trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ACAD (31.4% ROE) versus TURF (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, ACAD carries 119.0% implied volatility (20th %ile, Compressed (<25th %ile)), a 0.33x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (0.13β · 92% Vol realized risk). By comparison, TURF carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.47β · 16% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.